Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Eur Respir J
    September 2021
  1. AGARWAL R, Muthu V, Sehgal IS, Dhooria S, et al
    A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Sep 9. pii: 13993003.01787-2021.
    >> Share

  2. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
    Eur Respir J. 2021 Sep 2. pii: 13993003.00935-2021.
    >> Share

  3. GARCIA-LARSEN V
    Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
    Eur Respir J. 2021;58.
    >> Share

  4. RUFFLES T, Lipworth B, Mukhopadhyay S
    Considerations of a real life pragmatic clinical trial in adolescent asthma.
    Eur Respir J. 2021;58.
    >> Share

  5. VAN BOVEN JFM, Dierick BJH, Usmani OS
    When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
    Eur Respir J. 2021;58.
    >> Share

    August 2021
  6. ROFFEL MP, Boudewijn IM, van Nijnatten JLL, Faiz A, et al
    Identification of asthma associated microRNAs in bronchial biopsies.
    Eur Respir J. 2021 Aug 26. pii: 13993003.01294-2021.
    >> Share

  7. KEIR HR, Shoemark A, Huang JTJ, Chalmers JD, et al
    SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis.
    Eur Respir J. 2021 Aug 19. pii: 13993003.01840-2021.
    >> Share

  8. SUNJAYA AP, Allida SM, Di Tanna GL, Jenkins CR, et al
    Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01209-2021.
    >> Share

  9. WU M, Xie J, Wang Y, Tian Y, et al
    Greenness and eosinophilic asthma: Findings from the UK Biobank.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01597-2021.
    >> Share

  10. AFSHAR-MOHAJER N, Wu TD, Shade R, Brigham E, et al
    Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma.
    Eur Respir J. 2021 Aug 12. pii: 13993003.00209-2021.
    >> Share

  11. IZQUIERDO JL, Soriano JB
    Biologics may have a beneficial effect in asthma patients with COVID-19.
    Eur Respir J. 2021;58.
    >> Share

  12. ZEDER K, Avian A, Bachmaier G, Douschan P, et al
    Elevated pulmonary vascular resistance predicts mortality in COPD patients.
    Eur Respir J. 2021;58.
    >> Share

  13. HARTLEY T, Lane ND, Steer J, Elliott MW, et al
    The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation.
    Eur Respir J. 2021;58.
    >> Share

  14. BROXTERMAN RM, Wagner PD, Richardson RS
    Exercise training in COPD: muscle O2 transport plasticity.
    Eur Respir J. 2021;58.
    >> Share

    July 2021
  15. WECKMANN M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al
    COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
    Eur Respir J. 2021 Jul 29. pii: 13993003.03969-2020.
    >> Share

  16. BUSSE WW, Paggiaro P, Munoz X, Casale TB, et al
    Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.
    Eur Respir J. 2021 Jul 29. pii: 13993003.04605-2020.
    >> Share

  17. HAN YY, Forno E, Bacharier LB, Phipatanakul W, et al
    Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels.
    Eur Respir J. 2021 Jul 29. pii: 13993003.00989-2021.
    >> Share

  18. CORREN J, Katelaris CH, Castro M, Maspero JF, et al
    Effect of exacerbation history on clinical response to dupilumab in moderate-severe uncontrolled asthma.
    Eur Respir J. 2021 Jul 15. pii: 13993003.04498-2020.
    >> Share

  19. WARK PA, Pathinayake PS, Eapen MS, Sohal SS, et al
    Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00920-2021.
    >> Share

  20. SUNDE RB, Thorsen J, Pedersen CT, Stokholm J, et al
    Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00453-2021.
    >> Share

  21. RAMAKRISHNAN S, Couillard S
    Antibiotics for asthma attacks: masking uncertainty.
    Eur Respir J. 2021;58.
    >> Share

  22. MILNE S, Li X, Yang CX, Leitao Filho FS, et al
    Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial.
    Eur Respir J. 2021;58.
    >> Share

  23. YOUNG RP, Scott RJ
    Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
    Eur Respir J. 2021;58.
    >> Share

  24. LEVY L, Huszti E, Berra G, Renaud-Picard B, et al
    The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
    Eur Respir J. 2021;58.
    >> Share

  25. RUTTING S, Badal T, Wallis R, Schoeffel RE, et al
    Long-term variability of oscillatory impedance in stable obstructive airways disease.
    Eur Respir J. 2021;58.
    >> Share

  26. SCHENK P, Spiel AO, Huttinger F, Gmeiner M, et al
    Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.
    Eur Respir J. 2021;58.
    >> Share

  27. EVANGELOPOULOS D, Chatzidiakou L, Walton H, Katsouyanni K, et al
    Personal exposure to air pollution and respiratory health of COPD patients in London.
    Eur Respir J. 2021;58.
    >> Share

    June 2021
  28. MOORE WC, Kornmann O, Humbert M, Poirier C, et al
    Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
    Eur Respir J. 2021 Jun 25. pii: 13993003.00396-2021.
    >> Share

  29. KRAFT M, Brusselle G, Mark FitzGerald J, Pavord ID, et al
    Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
    Eur Respir J. 2021 Jun 10. pii: 13993003.00413-2021.
    >> Share

  30. THURSTON GD, Lee A
    Evidence of air pollution exposure and new asthma onset: further justification for cleaner air.
    Eur Respir J. 2021;57.
    >> Share

  31. WEATHERALL M
    Improving adherence to asthma medications: same-old, same-old?
    Eur Respir J. 2021;57.
    >> Share

  32. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2021;57.
    >> Share

  33. KUNISAKI KM, Sin DD
    Methylxanthines in COPD: yes to caffeine, no to theophylline.
    Eur Respir J. 2021;57.
    >> Share

  34. HULL JH, Jackson AR, Ranson C, Brown F, et al
    The benefits of a systematic assessment of respiratory health in illness-susceptible athletes.
    Eur Respir J. 2021;57.
    >> Share

  35. JENKINS CR, Wen FQ, Martin A, Barnes PJ, et al
    The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial.
    Eur Respir J. 2021;57.
    >> Share

  36. SANTOS LD, Antunes KH, Muraro SP, de Souza GF, et al
    TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection.
    Eur Respir J. 2021;57.
    >> Share

  37. BENINCASA G, DeMeo DL, Glass K, Silverman EK, et al
    Epigenetics and pulmonary diseases in the horizon of precision medicine: a review.
    Eur Respir J. 2021;57.
    >> Share

    May 2021
  38. JENDZJOWSKY N, Laing A, Malig M, Matyas J, et al
    Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty.
    Eur Respir J. 2021 May 28. pii: 13993003.00622-2021.
    >> Share

  39. BENLALA I, Dournes G, Girodet PO, Benkert T, et al
    Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging.
    Eur Respir J. 2021 May 28. pii: 13993003.00329-2021.
    >> Share

  40. SVERRILD A, Hansen S, Hvidtfeldt M, Clausson CM, et al
    The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM).
    Eur Respir J. 2021 May 28. pii: 13993003.01296-2021.
    >> Share

  41. HAKANSSON KEJ, Backer V, Suppli Ulrik C
    Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
    Eur Respir J. 2021 May 13. pii: 13993003.00741-2021.
    >> Share

  42. JOHANSSON H, Wollmer P, Sundstrom J, Janson C, et al
    Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS - normal values and relation to asthma and wheezing.
    Eur Respir J. 2021 May 6. pii: 13993003.00229-2021.
    >> Share

  43. BRUGIERE O, Verleden SE
    Putting the spotlight on macrophage-derived cathepsin in the pathophysiology of obliterative bronchiolitis.
    Eur Respir J. 2021;57.
    >> Share

  44. TAN WC, Bourbeau J, Nadeau G, Wang W, et al
    High eosinophil counts predict decline in FEV1: results from the CanCOLD study.
    Eur Respir J. 2021;57.
    >> Share

  45. MORRONE C, Smirnova NF, Jeridi A, Kneidinger N, et al
    Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome.
    Eur Respir J. 2021;57.
    >> Share

    April 2021
  46. MCLEESE RH, Spinou A, Alfahl Z, Tsagris M, et al
    Psychometrics of HRQoL questionnaires in bronchiectasis: A systematic review and meta-analysis.
    Eur Respir J. 2021 Apr 22. pii: 13993003.00025-2021.
    >> Share

  47. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    >> Share

  48. DURACK T, Chapman DG, Rutting S, Thamrin C, et al
    Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04400-2020.
    >> Share

  49. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    >> Share

  50. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    >> Share

  51. LUCCHETTI D, Santini G, Perelli L, Ricciardi-Tenore C, et al
    Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.
    Eur Respir J. 2021 Apr 1. pii: 13993003.03024-2020.
    >> Share

  52. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    >> Share

  53. SPITZER C, Ewert R, Volzke H, Frenzel S, et al
    Childhood maltreatment and lung function: findings from the general population.
    Eur Respir J. 2021;57.
    >> Share

    March 2021
  54. HIGBEE DH, Nava GW, Kwong ASF, Dodd JW, et al
    The impact of asthma on mental health & wellbeing during COVID-19 lockdown.
    Eur Respir J. 2021 Mar 25. pii: 13993003.04497-2020.
    >> Share

  55. BRUSSELLE G, Nicolini G, Santoro L, Guastalla D, et al
    BDP/formoterol MART asthma exacerbation benefit increases with blood eosinophil level.
    Eur Respir J. 2021 Mar 18. pii: 13993003.040982020.
    >> Share

  56. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.
    >> Share

  57. WEE LE, Conceicao EP, Tan JY, Sim JXY, et al
    Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore.
    Eur Respir J. 2021 Mar 2. pii: 13993003.04493-2020.
    >> Share

  58. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    >> Share

  59. BOTTLE A, Quint J
    COPD: still an unpredictable journey.
    Eur Respir J. 2021;57.
    >> Share

  60. CHAPMAN DG, King GG
    To recline is to relax? Not when you have COPD!
    Eur Respir J. 2021;57.
    >> Share

  61. COLAK Y
    Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD.
    Eur Respir J. 2021;57.
    >> Share

  62. CELLI B, Locantore N, Yates JC, Bakke P, et al
    Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
    Eur Respir J. 2021;57.
    >> Share

  63. WANG G, Hallberg J, Um Bergstrom P, Janson C, et al
    Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE.
    Eur Respir J. 2021;57.
    >> Share

  64. WING K, Williamson E, Carpenter JR, Wise L, et al
    Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
    Eur Respir J. 2021;57.
    >> Share

  65. DI CAMPLI MP, Azouz A, Assabban A, Scaillet J, et al
    The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.
    Eur Respir J. 2021;57.
    >> Share

  66. TIEW PY, Dicker AJ, Keir HR, Poh ME, et al
    A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.
    Eur Respir J. 2021;57.
    >> Share

  67. ELBEHAIRY AF, Faisal A, McIsaac H, Domnik NJ, et al
    Mechanisms of orthopnoea in patients with advanced COPD.
    Eur Respir J. 2021;57.
    >> Share

  68. WHITTAKER HR, Bloom C, Morgan A, Jarvis D, et al
    Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
    Eur Respir J. 2021;57.
    >> Share

    February 2021
  69. MASOLI M, Lanario JW, Hyland ME, Menzies-Gow A, et al
    The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID).
    Eur Respir J. 2021 Feb 25. pii: 13993003.00300-2021.
    >> Share

  70. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    >> Share

  71. CHANG AB, Fortescue R, Grimwood K, Alexopoulou E, et al
    Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Eur Respir J. 2021 Feb 11. pii: 13993003.02990-2020.
    >> Share

  72. BUSSE WW, Kraft M, Rabe KF, Deniz Y, et al
    Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03393-2020.
    >> Share

  73. WANG R, Alahmadi F, Niven R, Fowler SJ, et al
    Same-day repeatability of fractional exhaled nitric oxide in severe asthma.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03391-2020.
    >> Share

  74. REDDEL HK
    Reply: About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    >> Share

  75. FERRETTI S, Gelsomino M, Miceli Sopo S
    About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    >> Share

  76. PENN RB
    Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines.
    Eur Respir J. 2021;57.
    >> Share

  77. BRUSASCO C, Corradi F, Di Domenico A, Raggi F, et al
    Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    Eur Respir J. 2021;57.
    >> Share

  78. STOCKLEY RA
    COPD frequent exacerbators: time for the recycle bin?
    Eur Respir J. 2021;57.
    >> Share

  79. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study.
    Eur Respir J. 2021;57.
    >> Share

  80. CASS SP, Yang Y, Xiao J, McGrath JJC, et al
    Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD.
    Eur Respir J. 2021;57.
    >> Share

  81. SADATSAFAVI M, McCormack J, Petkau J, Lynd LD, et al
    Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Eur Respir J. 2021;57.
    >> Share

    January 2021
  82. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    >> Share

  83. GIAM YH, Shoemark A, Chalmers JD
    Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03157-2020.
    >> Share

  84. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    >> Share

  85. BEAULIEU D, Attwe A, Breau M, Lipskaia L, et al
    Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease.
    Eur Respir J. 2021 Jan 28. pii: 13993003.00752-2020.
    >> Share

  86. RUFFLES T, Jones CJ, Palmer C, Turner S, et al
    Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
    Eur Respir J. 2021 Jan 21. pii: 13993003.04107-2020.
    >> Share

  87. MAGNAYE KM, Naughton KA, Huffman J, Hogarth DK, et al
    A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
    Eur Respir J. 2021 Jan 14. pii: 13993003.03862-2020.
    >> Share

  88. MURRAY CS, Lucas SJ, Blakey J, Kaplan A, et al
    A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Eur Respir J. 2021 Jan 8. pii: 13993003.03599-2020.
    >> Share

  89. SIBILA O
    Reducing Pseudomonas sputum density in bronchiectasis.
    Eur Respir J. 2021;57.
    >> Share

  90. MOMEN NC, Liu X
    Maternal antibiotic use during pregnancy and asthma in children: population-based cohort study and sibling design.
    Eur Respir J. 2021;57.
    >> Share

  91. PLEASANTS RA, Tilley SL, Hickey AJ, Usmani OS, et al
    User-life of ICS/LABA inhaler devices should be considered when prescribed as relievers.
    Eur Respir J. 2021;57.
    >> Share

  92. SUNADOME H, Sato S, Matsumoto H, Murase K, et al
    Similar distribution of peripheral blood eosinophil counts in European and East Asian populations from investigations of large-scale general population studies: the Nagahama Study.
    Eur Respir J. 2021;57.
    >> Share

  93. LIN J, Huang N, Li J, Liu X, et al
    Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation.
    Eur Respir J. 2021;57.
    >> Share

  94. GUIBERT N, Guilleminault L, Lepage B, Heluain V, et al
    Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial.
    Eur Respir J. 2021;57.
    >> Share

    December 2020
  95. EGER K, Bel EH
    Asthma and COVID-19: do we finally have answers?
    Eur Respir J. 2020 Dec 30. pii: 13993003.04451-2020.
    >> Share

  96. MOORE A, Preece A, Sharma R, Heaney LG, et al
    A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Eur Respir J. 2020 Dec 17. pii: 13993003.03103-2020.
    >> Share

  97. KRUG J, Kiefer A, Koelle J, Vuorinen T, et al
    TLR 7/8 regulates Type I and Type III Interferon Signalling in RV1b induced Allergic Asthma.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01562-2020.
    >> Share

  98. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2020 Dec 10. pii: 13993003.030992020.
    >> Share

  99. LONGO C, Blais L, Brownell M, Quail JM, et al
    Association between asthma control trajectories in preschoolers and disease remission.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01897-2020.
    >> Share

  100. HERNANDEZ-PACHECO N, Vijverberg SJ, Herrera-Luis E, Li J, et al
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03388-2020.
    >> Share

  101. CHO PSP, Fletcher HV, Patel IS, Turner RD, et al
    Cough Hypersensitivity and Suppression in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03569-2020.
    >> Share

  102. O'BYRNE PM, Pavord ID
    A golden age of asthma research.
    Eur Respir J. 2020;56.
    >> Share

  103. WALTERS EH, Shukla SD, Ward C
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    >> Share

  104. HIGHAM A, Singh D
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    >> Share

    November 2020
  105. CRICHTON ML, Dudgeon EK, Shoemark A, Chalmers JD, et al
    Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03156-2020.
    >> Share

  106. FARNE H, Singanayagam A
    Why asthma might surprisingly protect against poor outcomes in COVID-19.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03045-2020.
    >> Share

  107. IZQUIERDO JL, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, et al
    The Impact of COVID-19 on Patients with Asthma.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03142-2020.
    >> Share

  108. MERKUS PJ, Pijnenburg MW
    Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice.
    Eur Respir J. 2020;56.
    >> Share

  109. WHITMORE GA, Aaron SD
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    >> Share

  110. PERRET JL, Vicendese D, Dharmage SC
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    >> Share

  111. SAHANIC S, Boehm A, Pizzini A, Sonnweber T, et al
    Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends.
    Eur Respir J. 2020;56.
    >> Share

    October 2020
  112. O'BYRNE PM, Reddel HK, Beasley R
    The Management of Mild Asthma.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03051-2020.
    >> Share

  113. YAN Q, Forno E, Herrera-Luis E, Pino-Yanes M, et al
    A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02693-2020.
    >> Share

  114. HANON S, Brusselle G, Deschampheleire M, Louis R, et al
    COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02857-2020.
    >> Share

  115. PAPI A, Braithwaite I, Ebmeier S, Hancox B, et al
    Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03064-2020.
    >> Share

  116. ILMARINEN P, Pardo A, Tuomisto LE, Vahatalo I, et al
    Long-term prognosis of new adult-onset asthma in obese patients.
    Eur Respir J. 2020 Oct 8. pii: 13993003.01209-2020.
    >> Share

  117. HOLZ O, Waschki B, Watz H, Kirsten A, et al
    Breath volatile organic compounds and inflammatory markers in adult asthma patients - negative results from the ALLIANCE cohort.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02127-2020.
    >> Share

  118. KERMANI NZ, Pavlidis S, Xie J, Sun K, et al
    Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01836-2020.
    >> Share

  119. O'NEILL C, Gibson PG, Heaney LG, Upham JW, et al
    The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02436-2020.
    >> Share

  120. QUINN M, Turner AM
    Modernising case finding for alpha1-antitrypsin deficiency by DNA sequencing of COPD patients.
    Eur Respir J. 2020;56.
    >> Share

  121. GLANVILLE AR
    Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction.
    Eur Respir J. 2020;56.
    >> Share

  122. CAVIEDES I, Soto R, Herth F
    The determination of ventilatory inefficiency at rest in COPD: the expected parameter.
    Eur Respir J. 2020;56.
    >> Share

    September 2020
  123. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
    Eur Respir J. 2020 Sep 25. pii: 13993003.02226-2020.
    >> Share

  124. ASHER MI, Garcia-Marcos L, Pearce NE, Strachan DP, et al
    "Trends in worldwide asthma prevalence".
    Eur Respir J. 2020 Sep 24. pii: 13993003.02094-2020.
    >> Share

  125. DAI X, Bui D, Perret JL, Lowe A, et al
    Exposure to household air pollution over 10 years is related to asthma and lung function decline.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00602-2020.
    >> Share

  126. THOMPSON CA, Eslick SR, Berthon BS, Wood LG, et al
    Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00612-2020.
    >> Share

  127. BURGESS JK, Jonker MR, Berg M, Ten Hacken NTH, et al
    Periostin: contributor to abnormal airway epithelial function in asthma?
    Eur Respir J. 2020 Sep 9. pii: 13993003.01286-2020.
    >> Share

  128. PASCOE CD, Jha A, Ryu MH, Ragheb M, et al
    Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction.
    Eur Respir J. 2020 Sep 3. pii: 13993003.00839-2020.
    >> Share

  129. ALIBERTI S, Sotgiu G, Martinez Garcia MA
    Blood eosinophils do not predict inhaled budesonide response in bronchiectasis.
    Eur Respir J. 2020;56.
    >> Share

  130. LIPWORTH B, Chan R, Kuo CR
    Systemic effects of fluticasone on blood eosinophils in bronchiectasis.
    Eur Respir J. 2020;56.
    >> Share

  131. CALVERLEY PMA, Farre R
    Oscillometry: old physiology with a bright future.
    Eur Respir J. 2020;56.
    >> Share

    August 2020
  132. LOEBINGER MR, Polverino E, Chalmers JD, Tiddens HAWM, et al
    Efficacy and safety of TOBI Podhaler(R) in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.
    Eur Respir J. 2020 Aug 27. pii: 13993003.01451-2020.
    >> Share

  133. LEE S, Lasky-Su JA, Lange C, Kim W, et al
    A Novel Locus for Exertional Dyspnea in Childhood Asthma.
    Eur Respir J. 2020 Aug 27. pii: 13993003.01224-2020.
    >> Share

  134. VEDEL-KROGH S, Rasmussen KL, Nordestgaard BG, Nielsen SF, et al
    Complement C3 and allergic asthma: A cohort study of the general population.
    Eur Respir J. 2020 Aug 18. pii: 13993003.00645-2020.
    >> Share

  135. HARRISON T, Canonica GW, Chupp G, Lee J, et al
    Real-world mepolizumab in the prospective severe asthma REALITI-A study - initial analysis.
    Eur Respir J. 2020 Aug 13. pii: 13993003.00151-2020.
    >> Share

  136. REIJULA J, Latvala J, Makela M, Siitonen S, et al
    Long-term trends of asthma, allergic rhinitis and atopic eczema in Finnish young men: a retrospective analysis, 19262017.
    Eur Respir J. 2020 Aug 6. pii: 13993003.02144-2019.
    >> Share

  137. CHALITSIOS CV, McKeever TM, Shaw DE
    Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study.
    Eur Respir J. 2020 Aug 6. pii: 13993003.01251-2020.
    >> Share

  138. WANG K, Verbakel JY, Oke J, Fleming-Nouri A, et al
    Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations.
    Eur Respir J. 2020;56.
    >> Share

  139. PEREZ DE LLANO L, Blanco Cid N, Martin Robles I, Golpe R, et al
    Regarding the role of F ENO in predicting failure after ICS reduction in mild-to-moderate asthma patients.
    Eur Respir J. 2020;56.
    >> Share

  140. LEUNG JM, Niikura M, Yang CWT, Sin DD, et al
    COVID-19 and COPD.
    Eur Respir J. 2020;56.
    >> Share

  141. JACOBS M, Van Eeckhoutte HP, Wijnant SRA, Janssens W, et al
    Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
    Eur Respir J. 2020;56.
    >> Share

  142. CONNELL D, Shah A
    The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic.
    Eur Respir J. 2020;56.
    >> Share

  143. NANZER AM, D'Ancona G, Kelly PA, Jackson DJ, et al
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    >> Share

  144. LIPWORTH B, Chan R, Kuo CR
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    >> Share

    July 2020
  145. BEURNIER A, Jutant EM, Jevnikar M, Boucly A, et al
    Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
    Eur Respir J. 2020 Jul 30. pii: 13993003.01875-2020.
    >> Share

  146. FREITAS PD, Xavier RF, McDonald VM, Gibson PG, et al
    Identification of asthma phenotypes based on extrapulmonary treatable traits.
    Eur Respir J. 2020 Jul 30. pii: 13993003.00240-2020.
    >> Share

  147. KENDZERSKA T, Aaron SD, To T, Licskai C, et al
    The Effect of Type and Dosage of Newly Prescribed Inhaled Corticosteroids on Obstructive Lung Disease and Pneumonia Hospitalisations in Older Individuals with Asthma, Chronic Obstructive Pulmonary Disease (COPD) or Both: A Retrospective Study of Healt
    Eur Respir J. 2020 Jul 23. pii: 13993003.02585-2020.
    >> Share

  148. PENN RB
    Mast cells in asthma: Here I am, stuck in the middle with you.
    Eur Respir J. 2020;56.
    >> Share

  149. FARSALINOS K, Angelopoulou A, Alexandris N, Poulas K, et al
    COVID-19 and the nicotinic cholinergic system.
    Eur Respir J. 2020;56.
    >> Share

  150. LEUNG JM, Sin DD
    Smoking, ACE-2 and COVID-19: ongoing controversies.
    Eur Respir J. 2020;56.
    >> Share

  151. MCALINDEN KD, Eapen MS, Lu W, Chia C, et al
    COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
    Eur Respir J. 2020;56.
    >> Share

  152. LUTCHMAN D
    Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
    Eur Respir J. 2020;56.
    >> Share

  153. VAN MEEL ER, Attanasi M, Jaddoe VWV, Reiss IKM, et al
    C hlamydia trachomatis during pregnancy and childhood asthma-related morbidity: a population-based prospective cohort.
    Eur Respir J. 2020;56.
    >> Share

  154. TO T, Viegi G, Cruz A, Taborda-Barata L, et al
    A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals.
    Eur Respir J. 2020;56.
    >> Share

  155. JOHNSON MJ, Ekstrom M, Currow DC
    Observational studies and "the eye of the beholder".
    Eur Respir J. 2020;56.
    >> Share

  156. KUGELMAN A
    High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?
    Eur Respir J. 2020;56.
    >> Share

  157. CHALMERS JD, Miravitlles M
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    >> Share

  158. AGUSTI A
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    >> Share

  159. TRINKMANN F, Watz H, Herth FJF
    Why do we still cling to spirometry for assessing small airway function?
    Eur Respir J. 2020;56.
    >> Share

  160. BOURDIN A, Gamez AS, Vachier I, Crestani B, et al
    LAM is another small airway disease: lessons from microCT.
    Eur Respir J. 2020;56.
    >> Share

  161. ARSHAD SH, Kurukulaaratchy R, Zhang H, Hodgekiss C, et al
    Assessing small airway function for early detection of lung function impairment.
    Eur Respir J. 2020;56.
    >> Share

    June 2020
  162. PORSBJERG CM, Sverrild A, Lloyd CM, Menzies-Gow AN, et al
    Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics.
    Eur Respir J. 2020 Jun 25. pii: 13993003.00260-2020.
    >> Share

  163. HINKS TS, Levine SJ, Brusselle GG
    Treatment options in type-2 low asthma.
    Eur Respir J. 2020 Jun 25. pii: 13993003.00528-2020.
    >> Share

  164. DURRINGTON HJ, Krakowiak K, Meijer P, Begley N, et al
    Circadian asthma airway responses are gated by REV-ERBalpha.
    Eur Respir J. 2020 Jun 25. pii: 13993003.02407-2019.
    >> Share

  165. GRAMEGNA A, Aliberti S, Sibila O, Di Francesco C, et al
    Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study.
    Eur Respir J. 2020 Jun 25. pii: 13993003.01702-2020.
    >> Share

  166. CHALMERS JD, Cipolla D, Thompson B, Davis AM, et al
    Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.
    Eur Respir J. 2020 Jun 18. pii: 13993003.00110-2020.
    >> Share

  167. MURRAY LM, Yerkovich ST, Ferreira MA, Upham JW, et al
    Risks for cold frequency vary by sex: role of asthma, age, TLR7 and leukocyte subsets.
    Eur Respir J. 2020 Jun 8. pii: 13993003.02453-2019.
    >> Share

  168. BLOMME EE, Provoost S, Bazzan E, Van Eeckhoutte HP, et al
    Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155.
    Eur Respir J. 2020 Jun 4. pii: 13993003.01289-2019.
    >> Share

  169. DE JONG CC, Pedersen ES, Mozun R, Muller-Suter D, et al
    Diagnosis of asthma in children: findings from the Swiss Paediatric Airway Cohort.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00132-2020.
    >> Share

  170. ORIANO M, Gramegna A, Terranova L, Sotgiu G, et al
    Sputum Neutrophil Elastase associates with microbiota and P. aeruginosa in bronchiectasis.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00769-2020.
    >> Share

  171. BARBIELLINI AMIDEI C, Comoretto R, Zanier L, Dona D, et al
    Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00197-2020.
    >> Share

  172. LEUNG JM, Yang CX, Sin DD
    Reply to: "Current smoking is not associated with COVID-19".
    Eur Respir J. 2020;55.
    >> Share

  173. ROSSATO M, Russo L, Mazzocut S, Di Vincenzo A, et al
    Current smoking is not associated with COVID-19.
    Eur Respir J. 2020;55.
    >> Share

  174. LEUNG JM, Yang CX, Sin DD
    COVID-19 and nicotine as a mediator of ACE-2.
    Eur Respir J. 2020;55.
    >> Share

  175. RUSSO P, Bonassi S, Giacconi R, Malavolta M, et al
    COVID-19 and smoking: is nicotine the hidden link?
    Eur Respir J. 2020;55.
    >> Share

  176. RUSSELL REK, Wang K
    Finding the true prevalence of obstructive lung disease: two steps forward and one step back.
    Eur Respir J. 2020;55.
    >> Share

  177. ROCHE N, Tonia T, Miravitlles M, Vaccaro V, et al
    Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards.
    Eur Respir J. 2020;55.
    >> Share

    May 2020
  178. WADA T, Jaw JE, Tsuruta M, Moritani K, et al
    External Radiofrequency as a Novel Extracorporeal Therapy for Emphysema.
    Eur Respir J. 2020 May 29. pii: 13993003.01422-2020.
    >> Share

  179. MUKHERJEE M, Forero DF, Tran S, Boulay ME, et al
    Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.
    Eur Respir J. 2020 May 22. pii: 13993003.00117-2020.
    >> Share

  180. BAGGOTT C, Hardy J, Sparks J, Holliday M, et al
    Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma - a pre-specified analysis from the PRACTICAL study, a randomised controlled trial.
    Eur Respir J. 2020 May 22. pii: 13993003.00170-2020.
    >> Share

  181. ROGLIANI P, Ritondo BL, Ora J, Cazzola M, et al
    SMART and as-needed therapies in mild to severe asthma: a network meta-analysis.
    Eur Respir J. 2020 May 19. pii: 13993003.00625-2020.
    >> Share

  182. TAYTARD J, Aupiais C, Jovien S, Assouline Kabla J, et al
    Effect of Long-Acting Beta-Agonist on bronchodilator response in asthmatic children.
    Eur Respir J. 2020 May 19. pii: 13993003.02010-2019.
    >> Share

  183. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Extrafine triple therapy in patients with asthma and persistent airflow limitation.
    Eur Respir J. 2020 May 19. pii: 13993003.00476-2020.
    >> Share

  184. ALIBERTI S, Sotgiu G, Blasi F, Saderi L, et al
    Blood eosinophils predict inhaled fluticasone response in bronchiectasis.
    Eur Respir J. 2020 May 12. pii: 13993003.00453-2020.
    >> Share

  185. EXARCHOS KP, Beltsiou M, Votti CA, Kostikas K, et al
    Artificial Intelligence techniques in Asthma:A systematic review and critical appraisal of the existing literature.
    Eur Respir J. 2020 May 7. pii: 13993003.00521-2020.
    >> Share

  186. HOANG TT, Sikdar S, Xu CJ, Lee MK, et al
    Epigenome-Wide Association Study of DNA Methylation and Adult Asthma in the Agricultural Lung Health Study.
    Eur Respir J. 2020 May 7. pii: 13993003.00217-2020.
    >> Share

  187. DURAND P, Guiddir T, Kyheng C, Blanc F, et al
    A Randomised Trial of High-Flow Nasal Cannula in Infants with Moderate Bronchiolitis.
    Eur Respir J. 2020 May 7. pii: 13993003.01926-2019.
    >> Share

  188. TAYLOR SL, Ivey KL, Gibson PG, Simpson JL, et al
    Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma.
    Eur Respir J. 2020 May 4. pii: 13993003.00194-2020.
    >> Share

  189. COSTELLO RW, Cushen B
    Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma.
    Eur Respir J. 2020;55.
    >> Share

  190. LEUNG JM, Yang CX, Tam A, Shaipanich T, et al
    ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
    Eur Respir J. 2020;55.
    >> Share

  191. DINH-XUAN AT, Brusselle G
    F ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma.
    Eur Respir J. 2020;55.
    >> Share

  192. STOLZ D, Miravitlles M
    The right treatment for the right patient with COPD: lessons from the IMPACT trial.
    Eur Respir J. 2020;55.
    >> Share

  193. VEDEL-KROGH S
    The search for the "healthy" blood eosinophil count.
    Eur Respir J. 2020;55.
    >> Share

  194. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    A clinically significant bronchodilator response in children: how should it be measured?
    Eur Respir J. 2020;55.
    >> Share

  195. GUEZGUEZ F, Ben Saad H
    What constitutes a "clinically significant" bronchodilator response in children?
    Eur Respir J. 2020;55.
    >> Share

  196. HALPIN DMG, Dransfield MT, Han MK, Jones CE, et al
    The effect of exacerbation history on outcomes in the IMPACT trial.
    Eur Respir J. 2020;55.
    >> Share

  197. SCHEERENS C, Faes K, Pype P, Beernaert K, et al
    Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.
    Eur Respir J. 2020;55.
    >> Share

  198. MATHIOUDAKIS AG, Bikov A, Foden P, Lahousse L, et al
    Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Eur Respir J. 2020;55.
    >> Share

  199. HARTL S, Breyer MK, Burghuber OC, Ofenheimer A, et al
    Blood eosinophil count in the general population: typical values and potential confounders.
    Eur Respir J. 2020;55.
    >> Share

  200. JOGDAND P, Siddhuraj P, Mori M, Sanden C, et al
    Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue.
    Eur Respir J. 2020;55.
    >> Share

  201. THULBORN SJ, Cane JL, Connolly C, Borg C, et al
    Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD.
    Eur Respir J. 2020;55.
    >> Share

  202. LEONG P, Ruane LE, Phyland D, Koh J, et al
    Inspiratory vocal cord closure in COPD.
    Eur Respir J. 2020;55.
    >> Share

    April 2020
  203. HANSEN ESH, Pitzner-Fabricius A, Toennesen LL, Rasmusen HK, et al
    Effect of aerobic exercise training on asthma in adults - A systematic review and meta-analysis.
    Eur Respir J. 2020 Apr 29. pii: 13993003.00146-2020.
    >> Share

  204. TOPPILA-SALMI S, Luukkainen AT, Xu B, Lampi J, et al
    Maternal smoking during pregnancy affects adult onset of asthma in offspring: a follow up from birth to age 46 years.
    Eur Respir J. 2020 Apr 27. pii: 13993003.01857-2019.
    >> Share

  205. PRETEROTI M, Whitmore GA, Vandemheen KL, Mark FitzGerald J, et al
    Population-Based Case-Finding to Identify Subjects with Undiagnosed Asthma or COPD.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00024-2020.
    >> Share

  206. IJPMA G, Kachmar L, Panariti A, Matusovsky OS, et al
    Intrapulmonary airway smooth muscle is hyperreactive with a distinct proteome in asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.02178-2019.
    >> Share

  207. GEHRING U, Wijga AH, Koppelman GH, Vonk JM, et al
    Air pollution and the development of asthma from birth until young adulthood.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00147-2020.
    >> Share

  208. BONVINI SJ, Birrell MA, Dubuis E, Adcock JJ, et al
    Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01458-2019.
    >> Share

  209. TURK Y, Theel W, van Huisstede A, van de Geijn GM, et al
    Short-term and long-term effect of a high intensity pulmonary rehabilitation program in obese patients with asthma: a randomised controlled trial.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01820-2019.
    >> Share

  210. NEALE J, Orme MW, Majd S, Chantrell S, et al
    A comparison of daily physical activity profiles between adults with severe asthma and healthy controls.
    Eur Respir J. 2020 Apr 7. pii: 13993003.02219-2019.
    >> Share

  211. CRICHTON ML, Lonergan M, Barker AF, Sibila O, et al
    Inhaled Aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies.
    Eur Respir J. 2020 Apr 7. pii: 13993003.00608-2020.
    >> Share

  212. TAILLE C, Chanez P, Devouassoux G, Didier A, et al
    Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.
    Eur Respir J. 2020 Apr 2. pii: 13993003.02345-2019.
    >> Share

  213. CHARRIOT J, Gaga M, Suehs C, Bourdin A, et al
    Asthma rescue treatments, time to reboot.
    Eur Respir J. 2020;55.
    >> Share

  214. CELLI B, Fabbri LM
    Urgent need of a management plan for survivors of COVID-19.
    Eur Respir J. 2020;55.
    >> Share

  215. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    Achieving the balance between evidence and simplicity.
    Eur Respir J. 2020;55.
    >> Share

  216. LIPWORTH B, Kuo CR, Chan R
    Making simple things complicated using anti-inflammatory reliever therapy.
    Eur Respir J. 2020;55.
    >> Share

  217. DIVO MJ
    The adipose tissue and lung health: like many things in life, the extremes are not good.
    Eur Respir J. 2020;55.
    >> Share

    March 2020
  218. NANZER A, Chowdhury A, Raheem A, Roxas C, et al
    Prevalence and Recovery of Adrenal Insufficiency in Steroid-Dependent Asthma Patients Receiving Biologic Therapy.
    Eur Respir J. 2020 Mar 26. pii: 13993003.02273-2019.
    >> Share

  219. VROMAN H, Tindemans I, Lukkes M, van Nimwegen M, et al
    Type II conventional DCs of asthmatic patients with frequent exacerbations have an altered phenotype and frequency.
    Eur Respir J. 2020 Mar 26. pii: 13993003.00859-2019.
    >> Share

  220. ALCARAZ-SERRANO V, Gimeno-Santos E, Scioscia G, Gabarrus A, et al
    Association between physical activity and risk of hospitalisation in bronchiectasis.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02138-2019.
    >> Share

  221. ALI MK, Kim RY, Brown AC, Mayall JR, et al
    Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma.
    Eur Respir J. 2020 Mar 17. pii: 13993003.01340-2019.
    >> Share

  222. HANCOX RJ, Morgan J, Dickson N, Connor J, et al
    Rape, asthma, and dysfunctional breathing.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02455-2019.
    >> Share

  223. FIELDING SS, Pijnenburg M, de Jongste J, Pike K, et al
    Does treatment guided by fractional exhaled nitric oxide improve outcomes in subgroups of children with asthma?
    Eur Respir J. 2020 Mar 12. pii: 13993003.01879-2019.
    >> Share

  224. TRAN TN, King E, Sarkar R, Nan C, et al
    Oral Corticosteroid Prescription Patterns for Asthma in France, Germany, Italy, and the United Kingdom.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02363-2019.
    >> Share

  225. GEALE K, Darabi H, Lindh M, Wahl HF, et al
    NORDSTAR - Paving the way for a new era in asthma research.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02476-2019.
    >> Share

  226. SHAHEEN SO, Gissler M, Devereux G, Erkkola M, et al
    Maternal iron supplementation in pregnancy and asthma in the offspring: follow-up of a randomised trial in Finland.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02335-2019.
    >> Share

  227. WANG K, Verbakel JY, Oke J, Fleming-Nouri A, et al
    Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02150-2019.
    >> Share

  228. SLOB EMA, Brew BK, Vijverberg SJH, Kats CJAR, et al
    Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02021-2019.
    >> Share

  229. HARVEY ES, Langton D, Katelaris C, Stevens S, et al
    Mepolizumab effectiveness and identification of super-responders in severe asthma.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02420-2019.
    >> Share

  230. LIPWORTH B, Kuo CR, Chan R
    Systemic potency of fluticasone in asthma.
    Eur Respir J. 2020;55.
    >> Share

  231. BUSSE WW
    Treatable traits: a step closer to the "holy grail" of asthma control?
    Eur Respir J. 2020;55.
    >> Share

  232. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    >> Share

  233. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    >> Share

  234. COLAK Y, Nordestgaard BG, Vestbo J, Lange P, et al
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    >> Share

  235. RENNARD SI
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    >> Share

  236. POLVERINO F, Soriano JB
    Small airways and early origins of COPD: pathobiological and epidemiological considerations.
    Eur Respir J. 2020;55.
    >> Share

    February 2020
  237. DEVULDER J, Chenivesse C, Ledroit V, Fry S, et al
    Aberrant anti-viral response of Natural Killer cell in severe asthma.
    Eur Respir J. 2020 Feb 27. pii: 13993003.02422-2018.
    >> Share

  238. D'ANCONA G, Kavanagh J, Roxas C, Green L, et al
    Adherence to Inhaled Corticosteroids and Clinical Outcomes in Mepolizumab Therapy for Severe Asthma.
    Eur Respir J. 2020 Feb 20. pii: 13993003.02259-2019.
    >> Share

  239. BAGGOTT C, Reddel HK, Hardy J, Sparks J, et al
    Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial.
    Eur Respir J. 2020 Feb 6. pii: 13993003.02073-2019.
    >> Share

  240. REDDEL HK
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    >> Share

  241. THOMSON NC, Chaudhuri R
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    >> Share

  242. SCHLEICH FN, Zanella D, Focant JF
    Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
    Eur Respir J. 2020;55.
    >> Share

  243. NILSSON U, Vanfleteren LEGW
    Troponin as a biomarker for mortality in stable COPD.
    Eur Respir J. 2020;55.
    >> Share

  244. ERGAN B, Scala R, Windisch W
    Defining "stable chronic hypercapnia" in patients with COPD: the physiological perspective.
    Eur Respir J. 2020;55.
    >> Share

  245. HEDSUND C, Wilcke TR, Berg RMG
    Defining "stable chronic hypercapnia" in patients with COPD: the physiological perspective.
    Eur Respir J. 2020;55.
    >> Share

    January 2020
  246. BACHERT C, Humbert M, Hanania NA, Zhang N, et al
    Staphylococcus aureus and its IgE-inducing Enterotoxins in Asthma: Current Knowledge.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01592-2019.
    >> Share

  247. COTTIN V, Nasser M, Traclet J, Chalabreysse L, et al
    Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01952-2019.
    >> Share

  248. HULS A, Vanker A, Gray D, Koen N, et al
    Genetic susceptibility to asthma increases the vulnerability to indoor air pollution.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01831-2019.
    >> Share

  249. MENZIES-GOW A, Mansur AH, Brightling CE
    Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01633-2019.
    >> Share

  250. NWARU BI, Ekstrom M, Hasvold P, Wiklund F, et al
    Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01872-2019.
    >> Share

  251. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
    Eur Respir J. 2020;55.
    >> Share

  252. BURGEL PR
    Airway mucus accumulation in COPD: the cholinergic paradox!
    Eur Respir J. 2020;55.
    >> Share

  253. LENFERINK A, van der Palen J, van der Valk PDLPM, Burt MG, et al
    It is time to further expand research in tailoring self-management of COPD exacerbations!
    Eur Respir J. 2020;55.
    >> Share

  254. RAMAKRISHNAN S, Bafadhel M
    Is it time to give up on "self-management" of COPD exacerbations?
    Eur Respir J. 2020;55.
    >> Share

  255. COLAK Y, Afzal S
    Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
    Eur Respir J. 2020;55.
    >> Share

  256. ADIBI A, Sadatsafavi M
    Looking at the COPD spectrum through "PRISm".
    Eur Respir J. 2020;55.
    >> Share

  257. BOURDIN A, Suehs C, Charriot J
    Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship.
    Eur Respir J. 2020;55.
    >> Share

  258. HAMAD G, Rigby A, Morice AH
    Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
    Eur Respir J. 2020;55.
    >> Share

    December 2019
  259. KIM S, Forno E, Yan Q, Jiang Y, et al
    SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium.
    Eur Respir J. 2019 Dec 12. pii: 13993003.02079-2019.
    >> Share

  260. ARSHAD SH, Hodgekiss C, Holloway JW, Kurukulaaratchy R, et al
    Association of asthma and smoking with lung function impairment in adolescence and early adulthood; the Isle of Wight Birth Cohort Study.
    Eur Respir J. 2019 Dec 12. pii: 13993003.00477-2019.
    >> Share

  261. MCDONALD VM, Clark VL, Cordova-Rivera L, Wark PAB, et al
    Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01509-2019.
    >> Share

  262. SERAJEDDINI H, Eddy RL, Licskai C, McCormack DG, et al
    FEV1 and MRI Ventilation Defect Reversibility in Asthma and COPD.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01947-2019.
    >> Share

  263. CABRERA CS, Nan C, Lindarck N, Beekman MJHI, et al
    SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting beta2-agonist use in asthma.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01858-2019.
    >> Share

  264. FOY B, Kay D, Siddiqui S, Brightling C, et al
    Increased ventilation heterogeneity in asthma can be attributed to proximal bronchioles.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01345-2019.
    >> Share

  265. TO T, Zhu J, Stieb D, Gray N, et al
    Early Life Exposure to Air Pollution and Incidence of Childhood Asthma, Allergic Rhinitis and Eczema.
    Eur Respir J. 2019 Dec 5. pii: 13993003.00913-2019.
    >> Share

  266. BOUSQUET J, Anto JM, Bachert C, Bosnic-Anticevich S, et al
    From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.
    Eur Respir J. 2019;54.
    >> Share

    November 2019
  267. ABDULLAH K, Zhu J, Gershon A, Dell S, et al
    Effect of asthma exacerbation during pregnancy in women with asthma: A population-based cohort study.
    Eur Respir J. 2019 Nov 26. pii: 13993003.01335-2019.
    >> Share

  268. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    >> Share

  269. KIM YM, Kim H, Lee S, Kim S, et al
    Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression.
    Eur Respir J. 2019 Nov 19. pii: 13993003.00827-2019.
    >> Share

  270. SUISSA S, Dell'Aniello S, Gonzalez AV, Ernst P, et al
    Inhaled corticosteroid use and the incidence of lung cancer in COPD.
    Eur Respir J. 2019 Nov 19. pii: 13993003.01720-2019.
    >> Share

  271. WANG L, Chitano P, Pare PD, Seow CY, et al
    Upregulation of smooth muscle Rho-kinase protein expression in human asthma.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01785-2019.
    >> Share

  272. OSEI ET, Brandsma CA, Timens W, Heijink IH, et al
    Current perspectives on the role of Interleukin-1 signaling in the pathogenesis of Asthma and COPD.
    Eur Respir J. 2019 Nov 14. pii: 13993003.00563-2019.
    >> Share

  273. VERMEULEN CJ, Xu CJ, Vonk JM, Ten Hacken NHT, et al
    Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01280-2019.
    >> Share

  274. GIBSON PG, Foster PS
    Neutrophilic asthma: welcome back!
    Eur Respir J. 2019;54.
    >> Share

  275. REDDEL HK
    Response: The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    >> Share

  276. AMIRAV I, Newhouse MT
    The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    >> Share

  277. GAGA M, Zervas E
    Oral steroids in asthma: a double-edged sword.
    Eur Respir J. 2019;54.
    >> Share


  278. ERJ November Podcast: Macrolides in severe asthma.
    Eur Respir J. 2019;54.
    >> Share

    October 2019
  279. COSTA CM, Neder JA, Verrastro CG, Paula-Ribeiro M, et al
    Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema.
    Eur Respir J. 2019 Oct 24. pii: 13993003.01319-2019.
    >> Share

  280. RADEMACHER J, Konwert S, Fuge J, Dettmer S, et al
    Anti-IL5 and anti-IL5Ralpha therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01333-2019.
    >> Share

  281. KATAYAMA S, Hammar KS, Krjutskov K, Einarsdottir E, et al
    Acute wheeze-specific gene module shows correlation with vitamin D and asthma medication.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01330-2019.
    >> Share

  282. ZHU Z, Zhu X, Liu CL, Shi H, et al
    Shared Genetics of Asthma and Mental Health Disorders: A Large-Scale Genome-Wide Cross-Trait Analysis.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01507-2019.
    >> Share

  283. FITZGERALD JM, Buhl R, Casale TB, Jugovic B, et al
    Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00964-2019.
    >> Share

  284. TANG HHF, Sly PD, Holt PG, Holt KE, et al
    Systems biology and big data in asthma and allergy - recent discoveries and emerging challenges.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00844-2019.
    >> Share

  285. DIMA AL, van Ganse E, Stadler G, de Bruin M, et al
    Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study.
    Eur Respir J. 2019 Oct 10. pii: 13993003.00901-2019.
    >> Share

  286. VAN BRAGT JJMH, Adcock IM, Bel EHD, Braunstahl GJ, et al
    Characteristics and treatment regimens across ERS SHARP severe asthma registries.
    Eur Respir J. 2019 Oct 10. pii: 13993003.01163-2019.
    >> Share

  287. PEROTIN JM, Djukanovic R, Davies DE
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    >> Share

  288. HIEMSTRA PS, Sterk PJ
    Translation of in vitro findings to patients with asthma: a timely and compelling challenge.
    Eur Respir J. 2019;54.
    >> Share

  289. WARD C, Kharaba ZJ
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    >> Share

  290. ANNESI-MAESANO I, Forastiere F
    Doubts about the adverse effects of air pollution on asthma?
    Eur Respir J. 2019;54.
    >> Share

  291. WARK PAB
    Why are people with asthma more susceptible to influenza?
    Eur Respir J. 2019;54.
    >> Share

    September 2019
  292. HOLGUIN F, Cardet JC, Chung KF, Diver S, et al
    Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline.
    Eur Respir J. 2019 Sep 26. pii: 13993003.00588-2019.
    >> Share

  293. MAIJERS I, Kearns N, Harper J, Weatherall M, et al
    Oral steroid sparing effect of high dose inhaled corticosteroids in asthma.
    Eur Respir J. 2019 Sep 26. pii: 13993003.01147-2019.
    >> Share

  294. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    >> Share

  295. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    Diagnosis of asthma in children: the contribution of a detailed history and test results.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01326-2019.
    >> Share

  296. HILES SA, McDonald VM, Guilhermino M, Brusselle GG, et al
    Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01381-2019.
    >> Share

  297. LEE H, Ryu J, Nam E, Chung SJ, et al
    Increased Mortality in Patients with Corticosteroid-dependent Asthma: A Nationwide Population-based Study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00804-2019.
    >> Share

  298. BRINKMAN P, Ahmed WM, Gomez C, Knobel HH, et al
    Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00544-2019.
    >> Share

  299. ARDURA-GARCIA C, Arias E, Hurtado P, Bonnett LJ, et al
    Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.02419-2018.
    >> Share

  300. LJUNGBERG H, Carleborg A, Gerber H, Ofverstrom C, et al
    Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial.
    Eur Respir J. 2019 Sep 3. pii: 13993003.00983-2019.
    >> Share

  301. PUHAN MA
    Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice.
    Eur Respir J. 2019;54.
    >> Share

  302. SOLTANI A, Mahmood MQ, Reid DW, Walters EH, et al
    Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation.
    Eur Respir J. 2019;54.
    >> Share

  303. SUISSA S
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    >> Share

  304. SUISSA S, Ariel A
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    >> Share

  305. ALMAGRO P, Martinez-Camblor P, Soriano JB
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    >> Share

  306. HARTLEY B, Criner GJ, Dransfield MT, Halpin DMG, et al
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    >> Share

  307. FOWLER SJ, Sterk PJ
    Breath biomarkers in asthma: we're getting answers, but what are the important questions?
    Eur Respir J. 2019;54.
    >> Share

  308. SPINOU A, Chalmers JD
    Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?
    Eur Respir J. 2019;54.
    >> Share

  309. ROCHE N, Anzueto A, Bosnic Anticevich S, Kaplan A, et al
    The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization.
    Eur Respir J. 2019;54.
    >> Share

    August 2019
  310. BOURDIN A, Bjermer L, Brightling C, Brusselle G, et al
    ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00900-2019.
    >> Share

  311. EVERAERTS S, McDonough JE, Verleden SE, Josipovic I, et al
    Airway morphometry in COPD with bronchiectasis: a view on all airway generations.
    Eur Respir J. 2019 Aug 29. pii: 13993003.02166-2018.
    >> Share

  312. RINGSHAUSEN FC, Rademacher J, Pink I, de Roux A, et al
    Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00499-2019.
    >> Share

  313. BULLONE M, Carriero V, Bertolini F, Folino A, et al
    Elevated serum IgE, OCS-dependence and IL-17/22 expression in highly neutrophilic asthma.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00068-2019.
    >> Share

  314. KELLY RS, Chawes BL, Guo F, Zhang L, et al
    The Role of the 17q21 Genotype in the Prevention of Early Childhood Asthma and Recurrent Wheeze by Vitamin D.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00761-2019.
    >> Share

  315. KRISHNA MT, Subramanian A, Adderley NJ, Zemedikun D, et al
    Allergic Diseases and Long Term Risk of Autoimmune Disorders: longitudinal cohort study and cluster analysis.
    Eur Respir J. 2019 Aug 14. pii: 13993003.00476-2019.
    >> Share

  316. CHACHI L, Diver S, Kaul H, Rebelatto MC, et al
    Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00930-2019.
    >> Share

  317. TOREN K, Olin AC, Johnsson A, Vikgren J, et al
    The association between cadmium exposure and chronic airflow limitation and emphysema: The Swedish CArdioPulmonary BioImage Study (SCAPIS Pilot).
    Eur Respir J. 2019 Aug 7. pii: 13993003.00960-2019.
    >> Share

  318. JHA A, Dunning J, Tunstall T, Thwaites RS, et al
    Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00949-2019.
    >> Share

  319. KHREIS H, Cirach M, Mueller N, de Hoogh K, et al
    Outdoor Air Pollution and the Burden of Childhood Asthma across Europe.
    Eur Respir J. 2019 Aug 7. pii: 13993003.02194-2018.
    >> Share

  320. PEJLER G
    The emerging role of mast cell proteases in asthma.
    Eur Respir J. 2019 Aug 1. pii: 13993003.00685-2019.
    >> Share

  321. SUOJALEHTO H, Suuronen K, Cullinan P
    Specific challenge testing for occupational asthma: revised handbook.
    Eur Respir J. 2019;54.
    >> Share

  322. GAGA M, Khaltaev N, Varghese C
    Inhaled corticosteroids in asthma and the need for universal health coverage.
    Eur Respir J. 2019;54.
    >> Share

  323. LAUBHAHN K, Schaub B
    Paediatric severe asthma: a need for novel innate molecular phenotypes.
    Eur Respir J. 2019;54.
    >> Share

  324. BOEHM A, Pizzini A, Sonnweber T, Loeffler-Ragg J, et al
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    >> Share

  325. ZHAO CN, Wu Q, Pan HF
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    >> Share

    July 2019
  326. SINTOBIN I, Siroux V, Holtappels G, Pison C, et al
    Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort.
    Eur Respir J. 2019 Jul 8. pii: 13993003.00198-2019.
    >> Share

  327. AZIM A, Barber C, Dennison P, Riley J, et al
    Exhaled volatile organic compounds in adult asthma: a systematic review.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00056-2019.
    >> Share

  328. BOULET LP, Reddel H, Bateman E, Pedersen S, et al
    The Global Initiative for Asthma (GINA): 25 years later.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00598-2019.
    >> Share

  329. LASKA IF, Chalmers JD
    Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?
    Eur Respir J. 2019;54.
    >> Share


  330. "Do bacteria have a role in asthma development?" J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469-471.
    Eur Respir J. 2019;54.
    >> Share

  331. MILANZI EB, Gehring U
    Detrimental effects of air pollution on adult lung function.
    Eur Respir J. 2019;54.
    >> Share

  332. LU W, Sharma P, Eapen MS, Sohal SS, et al
    Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis.
    Eur Respir J. 2019;54.
    >> Share

    June 2019
  333. PERSSON C
    In vivo observations provide insight into roles of eosinophils and epithelial cells in asthma.
    Eur Respir J. 2019 Jun 27. pii: 13993003.00470-2019.
    >> Share

  334. WILKINSON M, Maidstone R, Loudon A, Blaikley J, et al
    Circadian rhythm of exhaled biomarkers in health and asthma.
    Eur Respir J. 2019 Jun 20. pii: 13993003.01068-2019.
    >> Share

  335. JANSON C, Malinovschi A, Amaral AFS, Accordini S, et al
    Bronchodilator reversibility in asthma and COPD: Findings from three large population studies.
    Eur Respir J. 2019 Jun 20. pii: 13993003.00561-2019.
    >> Share

  336. FLEMING M, Fitton CA, Steiner MFC, McLay JS, et al
    Educational and health outcomes of children treated for asthma: Scotland-wide record linkage study of 683,716 children.
    Eur Respir J. 2019 Jun 13. pii: 13993003.02309-2018.
    >> Share

  337. NAGAKUMAR P, Puttur F, Gregory LG, Denney L, et al
    Pulmonary type2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids.
    Eur Respir J. 2019 Jun 4. pii: 13993003.01809-2018.
    >> Share

  338. OSCULLO YEPEZ G, Sierra-Parraga JM, Posadas Blazquez T, Martinez-Garcia MA, et al
    Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?
    Eur Respir J. 2019;53.
    >> Share

  339. REDDEL HK, FitzGerald JM, Bateman ED, Bacharier LB, et al
    GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.
    Eur Respir J. 2019;53.
    >> Share

  340. SORIANO JB
    The evolution of COPD species; or, something is changing for good in COPD.
    Eur Respir J. 2019;53.
    >> Share

  341. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    >> Share

    May 2019
  342. SHOEMARK A, Cant E, Carreto L, Smith A, et al
    A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Eur Respir J. 2019 May 31. pii: 13993003.00303-2019.
    >> Share

  343. RAVI A, Chowdhury S, Dijkhuis A, Bonta PI, et al
    Neutrophilic inflammation in asthma and defective epithelial translational control.
    Eur Respir J. 2019 May 20. pii: 13993003.00547-2019.
    >> Share

  344. VOGELBERG C, Szefler SJ, Vrijlandt EJLE, Boner AL, et al
    Tiotropium add-on therapy is safe and reduces seasonal worsenings in paediatric asthma patients.
    Eur Respir J. 2019 May 16. pii: 13993003.01824-2018.
    >> Share

  345. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
    Eur Respir J. 2019 May 2. pii: 13993003.01580-2018.
    >> Share

  346. CHOI H, Yang B, Nam H, Kyoung DS, et al
    Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.
    Eur Respir J. 2019 May 2. pii: 13993003.00194-2019.
    >> Share

  347. HOLLEY S, Knibb R, Latter S, Liossi C, et al
    Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ).
    Eur Respir J. 2019 May 2. pii: 13993003.01375-2018.
    >> Share

  348. O'BYRNE P, Fabbri LM, Pavord ID, Papi A, et al
    Asthma progression and mortality: The role of inhaled corticosteroids.
    Eur Respir J. 2019 May 2. pii: 13993003.00491-2019.
    >> Share

  349. MCBRIEN CN, Menzies-Gow A
    Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials.
    Eur Respir J. 2019;53.
    >> Share

  350. SCHLEICH F, Louis R
    It needs more than just eosinophils to cause emphysema in COPD.
    Eur Respir J. 2019;53.
    >> Share

  351. WALSH JA, Maddocks M, Man WD
    Supplemental oxygen during exercise training in COPD: full of hot air?
    Eur Respir J. 2019;53.
    >> Share

  352. SCHUETZ P, Stolz D
    Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall.
    Eur Respir J. 2019;53.
    >> Share

    April 2019
  353. PILLARISETTI N, Broderick D, Ainsworth A, Mulholland A, et al
    The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00704-2019.
    >> Share

  354. PEROTIN JM, Schofield JPR, Wilson SJ, Ward J, et al
    Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00453-2019.
    >> Share

  355. HENKLE E, Curtis JR, Chen L, Chan B, et al
    Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.
    Eur Respir J. 2019 Apr 18. pii: 13993003.01896-2018.
    >> Share

  356. TABEZE L, Marchand-Adam S, Borie R, Justet A, et al
    Severe asthma with blood hypereosinophilia associated with JAK2V617F mutation: a case series.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02248-2018.
    >> Share

  357. EFTHIMIOU J, Poll C, Barnes PJ
    Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02390-2018.
    >> Share

  358. LEHTO K, Pedersen NL, Almqvist C, Lu Y, et al
    Asthma and affective traits in adults: a genetically informative study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02142-2018.
    >> Share

  359. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    >> Share

  360. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    >> Share

  361. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    >> Share

  362. NANNINI LJ
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    >> Share

  363. MARTIN MJ, Harrison TW
    Is it time to move away from short-acting beta-agonists in asthma management?
    Eur Respir J. 2019;53.
    >> Share

  364. BOUSQUET J
    Electronic clinical decision support system (eCDSS) in the management of asthma: from theory to practice.
    Eur Respir J. 2019;53.
    >> Share

  365. HOBBS BD, Tantisira KG
    MicroRNAs in COPD: small molecules with big potential.
    Eur Respir J. 2019;53.
    >> Share

  366. ASHDOWN H, Steiner M
    Delivering high value therapies in COPD: the secret is in the marketing.
    Eur Respir J. 2019;53.
    >> Share

  367. WOUTERS EFM
    The Medusa faces of dyspnoea in COPD.
    Eur Respir J. 2019;53.
    >> Share

  368. SUISSA S, Ariel A
    Triple therapy in COPD: only for the right patient.
    Eur Respir J. 2019;53.
    >> Share

  369. PAPI A, Petruzzelli S, Vezzoli S, Georges G, et al
    Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.
    Eur Respir J. 2019;53.
    >> Share

    March 2019
  370. JIANG Y, Gruzieva O, Wang T, Forno E, et al
    Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents.
    Eur Respir J. 2019 Mar 28. pii: 13993003.00102-2019.
    >> Share

  371. WANG J, Pindus M, Janson C, Sigsgaard T, et al
    Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitis.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01921-2018.
    >> Share

  372. KUO CR, Lipworth B
    Differences in asthma control and lung function in relation to allergic status.
    Eur Respir J. 2019 Mar 17. pii: 13993003.02102-2018.
    >> Share

  373. PAPAKONSTANTINOU E, Savic S, Siebeneichler A, Strobel W, et al
    A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01941-2018.
    >> Share

  374. SHAHEEN SO, Lundholm C, Brew BK, Almqvist C, et al
    Prescribed analgesics in pregnancy and risk of childhood asthma.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01090-2018.
    >> Share

  375. MOKOKA MC, McDonnell MJ, MacHale E, Cushen B, et al
    Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy. Results from a systematic literature review and modelling study.
    Eur Respir J. 2019 Mar 7. pii: 13993003.02161-2018.
    >> Share

    February 2019
  376. BLOOM CI, Saglani S, Feary J, Jarvis D, et al
    Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006-2016.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02130-2018.
    >> Share

  377. DEN DEKKER HT, Burrows K, Felix JF, Salas LA, et al
    Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course.
    Eur Respir J. 2019 Feb 14. pii: 13993003.01795-2018.
    >> Share

  378. GUPTA S, Price C, Agarwal G, Chan D, et al
    The Electronic Asthma Management System (eAMS) Improves Primary Care Asthma Management.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02241-2018.
    >> Share

  379. DOYLE AD, Mukherjee M, LeSuer WE, Bittner TB, et al
    Eosinophil-derived IL-13 Promotes Emphysema.
    Eur Respir J. 2019 Feb 6. pii: 13993003.01291-2018.
    >> Share

  380. NAIR P, O'Byrne PM
    The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.
    Eur Respir J. 2019;53.
    >> Share

  381. SHTEINBERG M, Shah A, Elborn JS
    New insights into immunological responses to infection in bronchiectasis.
    Eur Respir J. 2019;53.
    >> Share

  382. PAHUS L, Jaffuel D, Vachier I, Bourdin A, et al
    Randomised controlled trials in severe asthma: selection by phenotype or stereotype.
    Eur Respir J. 2019;53.
    >> Share

  383. GUAN WJ, Han XR, de la Rosa-Carrillo D, Martinez-Garcia MA, et al
    The significant global economic burden of bronchiectasis: a pending matter.
    Eur Respir J. 2019;53.
    >> Share

    January 2019
  384. VAN DER MEER AN, de Jong K, Hoekstra-Kuik A, Bel EH, et al
    Dynamic hyperinflation impairs daily life activity in asthma.
    Eur Respir J. 2019 Jan 24. pii: 13993003.01500-2018.
    >> Share

  385. CHEN R, Zhang Q, Chen S, Tang H, et al
    IL-17F, rather than IL-17A, underlies airway inflammation in a steroid insensitive toluene diisocyanate-induced asthma model.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01510-2018.
    >> Share

  386. COTTIN V, Azuma A, Raghu G, Stansen W, et al
    Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01655-2018.
    >> Share

  387. CRAMER N, Sedlacek L, Tummler B, Welte T, et al
    Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02191-2018.
    >> Share

  388. PIETERS A, Bakker M, Hoek RAS, Altenburg J, et al
    The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral center.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02081-2018.
    >> Share

  389. ROTH M, Stolz D
    Biomarkers and personalised medicine for asthma.
    Eur Respir J. 2019;53.
    >> Share

  390. METERSKY ML, ZuWallack RL
    Pulmonary rehabilitation for bronchiectasis: if not now, when?
    Eur Respir J. 2019;53.
    >> Share

    December 2018
  391. TONGA KO, Berend N, Thamrin C, Farah CS, et al
    Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01028-2018.
    >> Share

  392. PAVLIDIS S, Takahashi K, Kwong FNK, Xie J, et al
    "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00938-2018.
    >> Share

  393. PATEL S, Cole AD, Nolan CM, Barker RE, et al
    Pulmonary rehabilitation in bronchiectasis: a propensity matched study.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01264-2018.
    >> Share

  394. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    >> Share

  395. DIEL R, Chalmers JD, Rabe KF, Nienhaus A, et al
    Economic burden of bronchiectasis in Germany.
    Eur Respir J. 2018 Dec 5. pii: 13993003.02033-2018.
    >> Share

    November 2018
  396. HANSEN AV, Ali Z, Malchau SS, Blafoss J, et al
    Fertility treatment among women with asthma - A case-control study of 3689 women with live births.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00597-2018.
    >> Share

  397. TUOMISTO LE, Ilmarinen P, Lehtimaki L, Tommola M, et al
    Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00904-2018.
    >> Share

  398. SHRIMANKER R, Pavord ID, Yancey S, Heaney LG, et al
    Exacerbations of severe asthma in patients treated with Mepolizumab.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01127-2018.
    >> Share

  399. WELLS JM, Colangelo LA, Sivarajan L, Thyagarajan B, et al
    Inflammation and Endothelial Activation in Early Adulthood are Associated with Future Emphysema: The CARDIA Lung Study.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01532-2018.
    >> Share

  400. BUSSE WW, Brusselle GG, Korn S, Kuna P, et al
    Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
    Eur Respir J. 2018 Nov 15. pii: 13993003.00948-2018.
    >> Share

  401. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2018;52.
    >> Share

  402. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    >> Share

  403. ALIBERTI S, Polverino E, Chalmers JD, Altenburg J, et al
    The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.
    Eur Respir J. 2018;52.
    >> Share

  404. DJUKANOVIC R, Adcock IM, Anderson G, Bel EH, et al
    The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
    Eur Respir J. 2018;52.
    >> Share

    October 2018
  405. BROWN T, Jones T, Gove K, Barber C, et al
    Randomised Controlled Trials in Severe Asthma: Selection by Phenotype or Stereotype.
    Eur Respir J. 2018 Oct 25. pii: 13993003.01444-2018.
    >> Share

  406. RUSCONI F, Fernandes RM, Pijnenburg MWH, Grigg J, et al
    The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers.
    Eur Respir J. 2018;52.
    >> Share

    September 2018
  407. CONTRERAS ZA, Chen Z, Roumeliotaki T, Annesi-Maesano I, et al
    Does early-onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.
    Eur Respir J. 2018 Sep 12. pii: 13993003.00504-2018.
    >> Share

  408. VOLMER T, Effenberger T, Trautner C, Buh R, et al
    Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature.
    Eur Respir J. 2018 Sep 6. pii: 13993003.00703-2018.
    >> Share

  409. BOAVENTURA R, Sibila O, Agusti A, Chalmers JD, et al
    Treatable traits in bronchiectasis.
    Eur Respir J. 2018;52.
    >> Share

  410. ARDURA-GARCIA C, Pedersen ESL, Goutaki M
    The limitations of cross-sectional data: perinatal risk factors for asthma.
    Eur Respir J. 2018;52.
    >> Share

  411. ADLER D
    Bridging the gap in knowledge between dyspnoea scientists and clinicians.
    Eur Respir J. 2018;52.
    >> Share

    August 2018
  412. BLEECKER ER, Wechsler ME, Mark FitzGerald J, Menzies-Gow A, et al
    Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe Asthma.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00936-2018.
    >> Share

  413. MILANZI EB, Koppelman GH, Smit HA, Wijga AH, et al
    Air pollution exposure and lung function until age 16: the PIAMA birth cohort study.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00218-2018.
    >> Share

  414. GOSENS R, Gross N
    The mode of action of anticholinergics in asthma.
    Eur Respir J. 2018 Aug 16. pii: 13993003.01247-2017.
    >> Share

  415. BEDARD A, Northstone K, Holloway JW, Henderson AJ, et al
    Maternal dietary antioxidant intake in pregnancy and childhood respiratory and atopic outcomes: birth cohort study.
    Eur Respir J. 2018 Aug 9. pii: 13993003.00507-2018.
    >> Share

  416. WESTBERG AP, Salonen MK, von Bondsdorff M, Osmond C, et al
    Maternal adiposity in pregnancy and offspring asthma in adulthood.
    Eur Respir J. 2018 Aug 2. pii: 13993003.01152-2018.
    >> Share

  417. MARTIN JG
    Airway smooth muscle may drive mucus hypersecretion in asthma.
    Eur Respir J. 2018;52.
    >> Share

  418. CULVER BH
    Assessment of severity and prognosis in COPD: moving beyond percent of predicted.
    Eur Respir J. 2018;52.
    >> Share

    July 2018
  419. AGARWAL R, Dhooria S, Singh Sehgal I, Aggarwal AN, et al
    A randomized trial of voriconazole and prednisolone monotherapy in acute-stage ABPA complicating asthma.
    Eur Respir J. 2018 Jul 26. pii: 13993003.01159-2018.
    >> Share

  420. POLVERINO E, Dimakou K, Hurst J, Angel Martinez-Garcia M, et al
    The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00328-2018.
    >> Share

  421. LEX C, Reuter M, Schuster A, Grabenhenrich L, et al
    Lung function trajectories using different reference equations in a birth cohort study up to the age of 20 years.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00364-2018.
    >> Share

  422. MES MA, Katzer CB, Chan AHY, Wileman V, et al
    Pharmacists and medication adherence in asthma: a systematic review and meta-analysis.
    Eur Respir J. 2018 Jul 5. pii: 13993003.00485-2018.
    >> Share

  423. ALLEN DJ, Holmes LJ, Hince KA, Daly R, et al
    Non-adherence with inhaled preventer therapy in severe asthmatic patients on long term Omalizumab.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01025-2018.
    >> Share

  424. ZHANG M, Litonjua AA, Mueller NT
    Maternal antibiotic use and child asthma: is the association causal?
    Eur Respir J. 2018;52.
    >> Share

  425. ANDRIANASOLO RM, Kesse-Guyot E, Adjibade M, Hercberg S, et al
    Associations between dietary scores with asthma symptoms and asthma control in adults.
    Eur Respir J. 2018;52.
    >> Share


  426. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecke
    Eur Respir J. 2018;52.
    >> Share

  427. YOHANNES AM
    Serotonergic antidepressants in COPD: beneficial or harmful?
    Eur Respir J. 2018;52.
    >> Share

  428. ERNST P
    Blood eosinophils in COPD and the future risk of pneumonia.
    Eur Respir J. 2018;52.
    >> Share

    June 2018
  429. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR).
    Eur Respir J. 2018 Jun 25. pii: 13993003.01927-2017.
    >> Share

  430. FAIZ A, Weckmann M, Tasena H, Vermeulen CJ, et al
    Profiling of healthy and asthmatic airway smooth muscle cells following IL-1beta treatment: a novel role for CCL20 in chronic mucus hyper-secretion.
    Eur Respir J. 2018 Jun 25. pii: 13993003.00310-2018.
    >> Share

  431. GOEMINNE CP, Cox B, Finch S, Loebinger MR, et al
    The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.
    Eur Respir J. 2018 Jun 14. pii: 13993003.02557-2017.
    >> Share

  432. MAC AOGAIN M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, et al
    IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00766-2018.
    >> Share

  433. RONIT A, Kristensen T, Hoseth VS, Abou-Kassem D, et al
    Computed tomography quantification of emphysema in people living with HIV and uninfected controls.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00296-2018.
    >> Share

  434. GOMEZ REAL F, Burgess JA, Villani S, Dratva J, et al
    Maternal age at delivery, lung function and asthma in offspring: a population-based survey.
    Eur Respir J. 2018;51.
    >> Share

  435. SUGIYAMA T
    A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle-bone unit.
    Eur Respir J. 2018;51.
    >> Share

  436. RICCI F, Wollmer P, Engstrom G, Fedorowski A, et al
    Dysregulation of the "inflammatory reflex" with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD.
    Eur Respir J. 2018;51.
    >> Share

  437. ANDREAS S
    The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation.
    Eur Respir J. 2018;51.
    >> Share

    May 2018
  438. DUFETELLE E, Bokov P, Delclaux C, Beydon N, et al
    Should reversibility be assessed in all asthmatic children with normal spirometry?
    Eur Respir J. 2018 May 31. pii: 13993003.00373-2018.
    >> Share

  439. HYLAND ME, Jones RC, Lanario JW, Masoli M, et al
    The construction and validation of the Severe Asthma Questionnaire (SAQ).
    Eur Respir J. 2018 May 24. pii: 13993003.00618-2018.
    >> Share

  440. SANDRI BJ, Kaplan A, Hodgson SW, Peterson M, et al
    Multi-Omic Molecular Profiling of Lung Cancer in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2018 May 24. pii: 13993003.02665-2017.
    >> Share

  441. BIDAD N, Barnes N, Griffiths C, Horne R, et al
    UNDERSTANDING PATIENTS' PERCEPTIONS OF ASTHMA CONTROL: A QUALITATIVE STUDY.
    Eur Respir J. 2018 May 17. pii: 13993003.01346-2017.
    >> Share

  442. BURGE PS, Moore VC, Robertson AS, Walters GI, et al
    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
    Eur Respir J. 2018 May 10. pii: 13993003.00059-2018.
    >> Share

  443. BOURBEAU J, Farias R
    Making sense of telemedicine in the management of COPD.
    Eur Respir J. 2018;51.
    >> Share

  444. EKSTROM M, Elmberg V, Lindow T, Wollmer P, et al
    Breathlessness measurement should be standardised for the level of exertion.
    Eur Respir J. 2018;51.
    >> Share

  445. BUSSE WW
    Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
    Eur Respir J. 2018;51.
    >> Share

  446. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    >> Share

    April 2018
  447. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    >> Share

  448. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    >> Share

  449. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    >> Share

  450. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    >> Share

  451. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Ekstrom M, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    >> Share

  452. RAMOS HERNANDEZ C, Nunez Fernandez M, Mouronte-Roibas C, Mosteiro Anon M, et al
    HypAir FeNO: an electrochemical sensor.
    Eur Respir J. 2018;51.
    >> Share

    March 2018
  453. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    >> Share

  454. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    >> Share

  455. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    >> Share

  456. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    >> Share

  457. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    >> Share

  458. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    >> Share

  459. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    >> Share

  460. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    >> Share

  461. PATTINSON KTS, Rowland MJ, Nickol AH, Quinlan J, et al
    Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.
    Eur Respir J. 2018;51.
    >> Share

    February 2018
  462. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    >> Share

  463. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    >> Share

  464. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    >> Share


  465. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    >> Share

  466. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    >> Share

  467. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  468. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    >> Share

  469. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    >> Share

  470. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    >> Share

  471. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    >> Share

  472. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    >> Share

  473. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    >> Share

  474. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    >> Share

  475. SIMILOWSKI T
    Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases.
    Eur Respir J. 2018;51.
    >> Share

  476. CRINER GJ
    Revising our approach to conducting therapeutic clinical research in COPD.
    Eur Respir J. 2018;51.
    >> Share

  477. HALPIN DMG
    Palliative care for people with COPD: effective but underused.
    Eur Respir J. 2018;51.
    >> Share

  478. SORIANO JB, Burgel PR
    On Don Quixote and pink puffers: multi-organ loss of tissue COPD.
    Eur Respir J. 2018;51.
    >> Share

  479. JONES R
    The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions?
    Eur Respir J. 2018;51.
    >> Share

  480. SOHAL SS
    Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules.
    Eur Respir J. 2018;51.
    >> Share

    January 2018
  481. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    >> Share

  482. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  483. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  484. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    >> Share

  485. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    >> Share

  486. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    >> Share

  487. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    >> Share

  488. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    >> Share

  489. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    >> Share

  490. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    >> Share

  491. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  492. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  493. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    >> Share

  494. MACNAUGHTON J, Oxley R, Rose A, Russell A, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    >> Share

  495. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Lansing R, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    >> Share

  496. AMBROSINO N
    Inspiratory muscle training in stable COPD patients: enough is enough?
    Eur Respir J. 2018;51.
    >> Share

  497. SPRUIT MA, Singh SJ, Rochester CL, Greening NJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    >> Share

  498. FOWLER SJ
    Breath analysis for label-free characterisation of airways disease.
    Eur Respir J. 2018;51.
    >> Share

  499. WILSON KC, Krishnan JA, Sliwinski P, Criner GJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    >> Share

  500. VANFLETEREN LEGW, Ullman A, Fabbri LM
    Time for a longer and better life for patients with COPD.
    Eur Respir J. 2018;51.
    >> Share

  501. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    >> Share

  502. CLINI E, Castaniere I, Tonelli R
    Looking for a chronic care model in COPD patients.
    Eur Respir J. 2018;51.
    >> Share

  503. SCHULTZ K, Jelusic D, Wittmann M, Kramer B, et al
    Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
    Eur Respir J. 2018;51.
    >> Share

  504. BEAUMONT M, Mialon P, Le Ber C, Le Mevel P, et al
    Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial.
    Eur Respir J. 2018;51.
    >> Share

  505. ALCAZAR-NAVARRETE B, Ruiz Rodriguez O, Conde Baena P, Romero Palacios PJ, et al
    Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.
    Eur Respir J. 2018;51.
    >> Share

  506. DE VRIES R, Dagelet YWF, Spoor P, Snoey E, et al
    Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    Eur Respir J. 2018;51.
    >> Share

  507. KESSLER R, Casan-Clara P, Koehler D, Tognella S, et al
    COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
    Eur Respir J. 2018;51.
    >> Share

  508. ROSE L, Istanboulian L, Carriere L, Thomas A, et al
    Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD(+)): a randomised controlled trial.
    Eur Respir J. 2018;51.
    >> Share

  509. STEURER-STEY C, Dalla Lana K, Braun J, Ter Riet G, et al
    Effects of the "Living well with COPD" intervention in primary care: a comparative study.
    Eur Respir J. 2018;51.
    >> Share

    December 2017
  510. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    >> Share

  511. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    >> Share

  512. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    >> Share

  513. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    >> Share

  514. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    >> Share

  515. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    >> Share

  516. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    >> Share

  517. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    >> Share

  518. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    >> Share

  519. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    >> Share

    November 2017
  520. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    >> Share

  521. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    >> Share

  522. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    >> Share

  523. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    >> Share

    October 2017
  524. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    >> Share

  525. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    >> Share

  526. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    >> Share

  527. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    >> Share


  528. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    >> Share

  529. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    >> Share

  530. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    >> Share

    September 2017
  531. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    >> Share

  532. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    >> Share

  533. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    >> Share

  534. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    >> Share

  535. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    >> Share

  536. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    >> Share

  537. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    >> Share

  538. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    >> Share


  539. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    >> Share

  540. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    >> Share

  541. CONRAD A, Janciauskiene S, Kohnlein T, Fuge J, et al
    Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation.
    Eur Respir J. 2017;50.
    >> Share

    July 2017
  542. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    >> Share

    June 2017
  543. SCHLAPBACH LJ, Straney L, Gelbart B, Alexander J, et al
    Burden of disease and change in practice in critically ill infants with bronchiolitis.
    Eur Respir J. 2017;49.
    >> Share

    May 2017
  544. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    >> Share

    April 2017
  545. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    >> Share

  546. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    >> Share

  547. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    >> Share

    March 2017
  548. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    >> Share

  549. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    >> Share

  550. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    >> Share

  551. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    >> Share

  552. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    >> Share

  553. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    >> Share

  554. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    >> Share

  555. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    >> Share

  556. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    >> Share

    February 2017
  557. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    >> Share

  558. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    >> Share

  559. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    >> Share

    January 2017
  560. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    >> Share

  561. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    >> Share

  562. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    >> Share

  563. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    >> Share

    November 2016
  564. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    >> Share

    April 2016
  565. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    >> Share

    March 2016
  566. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016